Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 440Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1VAMSI LABS LIMITED.

02 1Excella GmbH & Co. KG

03 1Fagron Inc

04 1Janssen Pharmaceutica NV

05 1LETCO MEDICAL, LLC

06 1MSN Life Sciences Private Limited

07 1Medisca Inc.

08 1Olon S.p.A.

09 1Professional Compounding Centers of America

10 1SICOR Societa' Italiana Corticosteroidi s.r.l.

11 1Spectrum Laboratory Products, Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

HALOPERIDOL

NDC Package Code : 66412-0506

Start Marketing Date : 2021-01-05

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

Vamsi Labs

02

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

HALOPERIDOL

NDC Package Code : 51552-0519

Start Marketing Date : 2004-09-01

End Marketing Date : 2025-04-30

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

04

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

HALOPERIDOL

NDC Package Code : 12578-617

Start Marketing Date : 1989-02-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

HALOPERIDOL

NDC Package Code : 62991-2031

Start Marketing Date : 2010-12-18

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

06

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

HALOPERIDOL

NDC Package Code : 38779-0330

Start Marketing Date : 2014-07-21

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

07

The Generic Rx Session
Not Confirmed
arrow

08

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

HALOPERIDOL

NDC Package Code : 51927-0203

Start Marketing Date : 2018-12-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

HALOPERIDOL

NDC Package Code : 48292-0007

Start Marketing Date : 2015-02-13

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (100kg/100kg)

Marketing Category : BULK INGREDIENT

blank

10

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

HALOPERIDOL

NDC Package Code : 49452-3446

Start Marketing Date : 1994-06-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

Looking for 52-86-8 / Haloperidol API manufacturers, exporters & distributors?

Haloperidol manufacturers, exporters & distributors 1

93

PharmaCompass offers a list of Haloperidol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Haloperidol manufacturer or Haloperidol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Haloperidol manufacturer or Haloperidol supplier.

PharmaCompass also assists you with knowing the Haloperidol API Price utilized in the formulation of products. Haloperidol API Price is not always fixed or binding as the Haloperidol Price is obtained through a variety of data sources. The Haloperidol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Haloperidol

Synonyms

52-86-8, Haldol, Serenace, Aloperidin, Eukystol, Aloperidol

Cas Number

52-86-8

Unique Ingredient Identifier (UNII)

J6292F8L3D

About Haloperidol

A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)

Haloperidol Manufacturers

A Haloperidol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Haloperidol, including repackagers and relabelers. The FDA regulates Haloperidol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Haloperidol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Haloperidol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Haloperidol Suppliers

A Haloperidol supplier is an individual or a company that provides Haloperidol active pharmaceutical ingredient (API) or Haloperidol finished formulations upon request. The Haloperidol suppliers may include Haloperidol API manufacturers, exporters, distributors and traders.

click here to find a list of Haloperidol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Haloperidol NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Haloperidol as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Haloperidol API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Haloperidol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Haloperidol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Haloperidol NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Haloperidol suppliers with NDC on PharmaCompass.

Haloperidol Manufacturers | Traders | Suppliers

Haloperidol Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.